NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-093-2022-0-PC-01 COMPOSITIONS AND METHODS FOR DETECTING LYMPHATIC FILARIASIS PCT PCT PCT/US2023/067703 Pending
NCI E-167-2017-0-JP-01 NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY JP DIV 2023-090523 Pending
NIAID E-169-2023-0-US-01 HIV-1 Envelope Triple Tandem Trimers US 63/469,773 Expired
NCI E-180-2023-0-US-01 Method for manufacturing TCR-T cell therapy products targeting tumor antigen(s) from patients with HIV and cancer US 63/469,641 Expired
NIDCR E-011-2023-0-US-01 COPIPARVOVIRUS GENETIC VECTOR PLATFORM US 63/469,337 Expired
NCI E-495-2013-0-US-02 ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS US CON 18/323,493 Pending
NIAID E-014-2023-0-US-01 HUMAN MONOCLONAL ANTIBODIES THAT TARGET THE RH5 COMPLEX OF BLOOD-STAGE PLASMODIUM FALCIPARUM US 63/468,740 Expired
NCI E-202-2020-0-AU-01 TYROSYL-LOCK PEPTIDES AU National Stage 2021385049 Pending
NCI E-099-2023-1-US-01 T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME US 63/503,578 Expired
NIAID E-103-2022-0-PC-01 Replicating RNA Vaccine For Crimean-Congo Hemorrhagic Fever Virus PCT PCT PCT/US2023/067226 Pending
NIAID E-021-2021-0-US-02 NOVEL VAR2CSA IMMUNOGENS AND METHODS OF USE THEREOF US National Stage 18/037,837 Pending
NCI E-086-2012-2-US-11 Methods for Generation of Pluripotent and Multipotent Cells US CON 18/320,244 Pending
NHLBI E-005-2021-0-EP-01 MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE EP National Stage 21830819.5 Pending
NCI E-202-2020-0-US-02 TYROSYL-LOCK PEPTIDES US National Stage 18/037,379 Pending
NCI E-172-2022-0-PC-01 Method Of Subtyping Of Small Cell Lung Cancer Using Plasma Cell-Free Nucleosomes PCT PCT PCT/IL2023/050509 Pending
NCI E-202-2020-0-CA-01 TYROSYL-LOCK PEPTIDES CA National Stage 3199368 Pending
NIAID E-240-2020-0-US-01 RECOMBINANT MURINE PNEUMONIA VIRUS EXPRESSING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN US 63/502,829 Expired
NCI E-099-2014-0-US-02 USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS US CON 18/318588 Pending
NCI E-171-2020-0-EP-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection EP National Stage 21851911.4 Pending
NCATS E-234-2020-0-US-02 Small Molecule Inhibitors of Sars-Cov-2 Infections US National Stage 18/253,031 Pending
NICHD E-003-2014-0-US-02 MONOCLONAL ANTIBODIES THAT SPECIFICALLY BIND TO MATRILIN 3 AND THEIR USE US CON 18/317,869 Abandoned
NIBIB E-007-2021-0-EP-01 ANTIBODY SPECIFIC FOR SARS]COV]2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS EP National Stage 21802499.0 Pending
NCI E-129-2023-0-US-01 SINGLE DOMAIN ANTIBODIES THAT SPECIFICALLY BIND THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITIONS AND USES THEREOF US 63/501,772 Expired
NCI E-094-2022-0-PC-01 PIM-TARGETED PROTACS AND METHODS OF USE PCT PCT PCT/US2023/022017 Pending
NLM E-125-2017-2-JP-01 CRYSTAL STRUCTURE OF CRISPR CPF1 JP DIV 2023-079002 Pending
NCI E-126-2022-0-PC-01 VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1 PCT PCT PCT/US2023/066839 Pending
NHLBI E-197-2020-0-US-02 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING US National Stage 18/036,392 Pending
NHLBI E-197-2020-0-IL-01 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING IL National Stage 302823 Pending
NICHD E-010-2021-0-US-02 ENHANCED ANTIGEN REACTIVITY OF IMMUNE CELLS EXPRESSING A MUTANT NON-SIGNALING CD3 ZETA CHAIN US National Stage 18/036,112 Pending
NIAID E-066-2014-0-US-02 STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US DIV 18/314,052 11969466 Issued PDF
NICHD E-115-2022-0-PK-01 NESTORONE® / TESTOSTERONE TRANSDERMAL GEL PK ORD 272/2023 Pending
NICHD E-115-2022-0-BD-01 NESTORONE® / TESTOSTERONE TRANSDERMAL GEL BD ORD 125/2023 Pending
NHLBI E-061-2022-0-PC-01 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL RESYNCHRONIZATION AND PACING PCT PCT PCT/US2023/021238 Expired
NINDS E-130-2022-3-CN-02 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE CN DIV 202310498623.5 Pending
NCI E-167-2019-0-CN-01 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY CN National Stage 202180074998.8 Pending
NIAID E-109-2023-0-US-01 NEUTRALIZING ANTIBODIES TO DENGUE VIRUS E PROTEIN AND THEIR USE US 63/464,370 Expired
NICHD E-115-2022-0-PCT-02 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL PCT PCT PCT/US2023/021154 Pending
NHLBI E-119-2022-0-PC-01 SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE PCT PCT PCT/US2023/066617 Expired
NCI E-231-2020-0-US-01 METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY US National Stage 18/251,751 Pending
NCI E-060-2021-0-US-02 ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF US National Stage 18/035,427 Pending
NHLBI E-005-2021-0-US-02 MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE US National Stage 18/035,240 Pending
NCI E-048-2022-0-PC-01 COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS PCT PCT PCT/US2023/066487 Expired
NCI E-068-2018-0-US-02 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 US CON 18/310,744 Pending
NCI E-265-2015-0-US-02 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS US CON 18/310,141 Pending
NHGRI E-134-2023-0-US-01 SYNTHETIC MMAB GENES AND AAV VECTORS TO TREAT COBALAMIN B DEFICIENCY US 63/499,013 Expired
NCI E-189-2020-1-AU-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION AU National Stage 2021351710 Pending
NCI E-189-2020-1-KR-01 HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION KR National Stage 10-2023-7014854 Pending
NCI E-150-2020-0-US-02 Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome US National Stage 18/250,816 Pending
NINDS E-113-2022-1-PCT-01 RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2 PCT PCT PCT/US2023/066224 Expired
NIBIB E-118-2022-0-PC-01 MICROFLUIDIC DEVICES FOR EVALUATING FIBROSIS IN MATERIAL IMPLANTATION AND CANCER PCT PCT PCT/US2023/020026 Expired